Glenmarkâs entry into specialty pharma could unlock new growth opportunities, while rising competition keeps analysts cautious on Ola Electric and DMart, says Amnish Aggarwal, Head of Research at Prabhudas Lilladher. He also flaged selective opportunities in EMS players like Syrma and expects EPC stocks to gain traction as fresh government capex allocations approach.